The INCATE Selection Committee has selected five promising ventures to receive Stage I support. Want to find out who they are? Explore the latest additions and learn more about the innovative ideas moving forward in [...]
More news
Just before turning the page to 2025, it's a moment to reflect on the progress [...]
We are thrilled to announce a significant milestone for Invitris—a $650,000 deal plus royalties with [...]
2024 has been a transformative year for Xiretsa, filled with exciting milestones and promising opportunities. [...]
INCATE is pleased to invite researchers, clinicians, and industry experts to submit articles for an [...]
Kinzbio’s mission is to harness the power of phages—nature's precision antimicrobials—to address some of the [...]
The BamA Inhibitor project (Justus-Liebig-University Giessen) has been awarded a prestigious €180k grant through the [...]
November 5th, 2024 – INCATE (the INCubator for Antibacterial Therapies in Europe) is pleased to [...]
© Marek Kruszewski Researchers from the Helmholtz Centre for Infection Research in Braunschweig [...]
